SCHEMBL1309770

SCHEMBL1309770

O=C1CCC/C1=C/NCc1ccccc1

nearest known ligand 0.94

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.94
ALDH1A1 P00352 12/20 0.69
USP2 O75604 1/20 0.64
SMN1; SMN2 Q16637 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
HTT P42858 1/20 0.50
ADH1B P00325 1/20 0.47
ADH1C P00326 1/20 0.47
ADH1A P07327 1/20 0.47
ADH7 P40394 1/20 0.47
KDM4E B2RXH2 6/20 0.46
MAPT P10636 4/20 0.46
HSD17B10 Q99714 3/20 0.46
HPGD P15428 3/20 0.46
POLB P06746 1/20 0.44
RAB9A P51151 1/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 1/20 0.41
THRB P10828 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1309772 1.00 KMT2A (0.94) KMT2AALDH1A1USP2SMN1; SMN2L3MBTL1
SCHEMBL3476346 0.84 KMT2A (0.68) KMT2AALDH1A1USP2SMN1; SMN2L3MBTL1
SCHEMBL14972764 0.80 KMT2A (0.66) KMT2AALDH1A1USP2SMN1; SMN2L3MBTL1
SCHEMBL14972763 0.80 KMT2A (0.66) KMT2AALDH1A1USP2SMN1; SMN2L3MBTL1
SCHEMBL19043443 0.77 KMT2A (0.57) KMT2AALDH1A1USP2SMN1; SMN2L3MBTL1
SCHEMBL21238089 0.76 KMT2A (0.61) KMT2AALDH1A1USP2SMN1; SMN2L3MBTL1
SCHEMBL1310500 0.75 KMT2A (0.60) KMT2AALDH1A1USP2SMN1; SMN2L3MBTL1
SCHEMBL5594322 0.70 KMT2A (0.58) KMT2AALDH1A1USP2SMN1; SMN2L3MBTL1
SCHEMBL1311442 0.68 KMT2A (0.48) KMT2AALDH1A1SMN1; SMN2L3MBTL1HTT
SCHEMBL809809 0.68 KMT2A (0.48) KMT2AALDH1A1HTTMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846125-B2 Enaminocarbonyl compounds and their use INSTYTUT CHEMII ORGANICZNEJ, POLSKA AKADEMIA NAUK (PL) 2014-09-30 US claimed
EP-2391614-B1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE INST CHEMII ORGANICZNEJ POLSKA AKADEMIA NAUK (PL) 2013-05-29 EP claimed
EP-2391614-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE Instytut Chemii Organicznej, Polska Akademia Nauk (PL) 2011-12-07 EP claimed
US-20110274803-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE INSTYTUT CHEMII ORGANICZNEJ, POLSKA AKADEMIA NAUK (PL) 2011-11-10 US claimed
WO-2010087727-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE INSTYTUT CHEMII ORGANICZNEJ, POLSKA AKADEMIA NAUK (PL) 2010-08-05 WO claimed
US-8846125-B2 Enaminocarbonyl compounds and their use INSTYTUT CHEMII ORGANICZNEJ, POLSKA AKADEMIA NAUK (PL) 2014-09-30 US disclosed
EP-2391614-B1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE INST CHEMII ORGANICZNEJ POLSKA AKADEMIA NAUK (PL) 2013-05-29 EP disclosed
EP-2391614-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE Instytut Chemii Organicznej, Polska Akademia Nauk (PL) 2011-12-07 EP disclosed
US-20110274803-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE INSTYTUT CHEMII ORGANICZNEJ, POLSKA AKADEMIA NAUK (PL) 2011-11-10 US disclosed
WO-2010087727-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE INSTYTUT CHEMII ORGANICZNEJ, POLSKA AKADEMIA NAUK (PL) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110274803-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE TAS2R42, TAS2R41, TAS2R1 KMT2A 1458/4885ALDH1A1 1125/4885USP2 3791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.